Cell therapy for Huntington's disease, the next step forward.
Peschanski
Marc
M
INSERM U 421/IM3, Neuroplasticity and Therapeutics, Faculté de Médecine, Créteil, France. peschanski@im3.inserm.fr
Dunnett
Steve B
SB
D000818:Animals; D017690:Cell Transplantation / Q000379:methods*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D016332:Fetal Tissue Transplantation / Q000379:methods*; D006801:Humans; D006816:Huntington Disease / Q000601:surgery*